ZKH Group Limited
ZKH Group Limited (ZKH) Financial Performance & Income Statement Overview
Analyze ZKH Group Limited (ZKH) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
ZKH Group Limited (ZKH) Income Statement & Financial Overview
Analyze ZKH Group Limited’s ZKH earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.37B | $2.28B | $2.25B | $1.86B |
| Cost of Revenue | $1.97B | $1.89B | $1.87B | $1.53B |
| Gross Profit | $405.00M | $388.41M | $382.99M | $334.08M |
| Gross Profit Ratio | $0.17 | $0.17 | $0.17 | $0.18 |
| R&D Expenses | $162.40M | $49.78M | $38.43M | $39.84M |
| SG&A Expenses | $396.14M | $343.80M | $316.68M | $326.51M |
| Operating Expenses | $1.78B | $493.76M | $454.20M | $463.69M |
| Total Costs & Expenses | $2.40B | $2.39B | $2.32B | $1.99B |
| Interest Income | $61.78M | $17.28M | $14.45M | $18.05M |
| Interest Expense | $18.30M | $4.97M | $5.52M | $5.70M |
| Depreciation & Amortization | $18.37M | $29.16M | $10.51M | $2.54M |
| EBITDA | -$14.22M | -$76.19M | -$60.70M | -$85.12M |
| EBITDA Ratio | -$0.006 | -$0.03 | -$0.03 | -$0.05 |
| Operating Income | -$323.76M | -$105.36M | -$71.21M | -$129.61M |
| Operating Income Ratio | -$0.14 | -$0.05 | -$0.03 | -$0.07 |
| Other Income/Expenses (Net) | $294.92M | $24.20M | $4.99M | $38.80M |
| Income Before Tax | -$28.83M | -$81.16M | -$66.22M | -$90.81M |
| Income Before Tax Ratio | -$0.01 | -$0.04 | -$0.03 | -$0.05 |
| Income Tax Expense | $929000.00 | $591000.00 | $66000.00 | $88000.00 |
| Net Income | -$29.10M | -$81.75M | -$66.29M | -$90.90M |
| Net Income Ratio | -$0.01 | -$0.04 | -$0.03 | -$0.05 |
| EPS | -$6.30 | -$17.50 | -$14.00 | -$19.60 |
| Diluted EPS | -$6.30 | -$17.50 | -$14.00 | -$19.60 |
| Weighted Avg Shares Outstanding | $4.66M | $4.68M | $4.69M | $4.68M |
| Weighted Avg Shares Outstanding (Diluted) | $4.66M | $4.68M | $4.69M | $4.68M |
The company's financials show resilient growth, with revenue advancing from $1.86B in Q1 2024 to $2.37B in Q4 2024. Gross profit remained healthy with margins at 17% in Q4 2024 compared to 18% in Q1 2024. Operating income hit -$323.76M last quarter, sustaining a consistent -14% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$14.22M. Net income rose to -$29.10M, while earnings per share reached -$6.30. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan